US Patent Issued to ARES TRADING on April 8 for "Cladribine regimen for treating progressive forms of multiple sclerosis" (American, German Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,703, issued on April 8, was assigned to ARES TRADING S.A. (Eysins, Switzerland).

"Cladribine regimen for treating progressive forms of multiple sclerosis" was invented by Fernando Dangond (Weston, Mass.) and Matthias Dotzauer (Erzhausen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine can be effective for the treatment of progressive forms of Multiple Sclerosis, especially Primary Progressive Multiple Sclerosis and/or Secondary Progressive Multiple Sclerosis. Methods of treatment can be based on specific oral dosings, specific oral dosag...